Perspective Therapeutics Inc CATX

Healthcare Biotechnology

Perspective Therapeutics, Inc. is a radiopharmaceutical development company that is developing advanced treatment applications for cancers throughout the body. The Company has proprietary technology that utilizes the alpha-emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides. It is also developing imaging diagnostics that incorporate the same targeting peptides, which provide the opportunity to personalize treatment and optimize patient outcomes. This theranostic approach enables the ability to see the specific tumor and then treat it to potentially improve efficacy and minimize toxicity. The Company's melanoma (VMT01) and neuroendocrine tumor (VMT-a-NET) programs have entered Phase I/IIa imaging and therapy trials for the treatment of metastatic melanoma and neuroendocrine tumors at several academic institutions. It has also developed a 212Pb generator to secure key isotopes for clinical trial and commercial operations.

NYSEAM:CATX - Post by User

Perspective Therapeutics Inc

Bullboard Posts

Post by kingposton Aug 04, 2015 2:35pm

269 Views

Post# 23987815

ISR up 20% today ...short squeeze?

Not sure yet what the reason is for the price surge but lets just say I expected it since 7,000,000 short and the fabricated bashinging/fake lawsuits campain by expected offshore hedgies /crookedB.Pharma manipulators....a shame since their cancer treatment id FDA approved and world class and highly effective IMO...

Bullboard Posts

@ the Bell: TSX advances to start off Christmas trading week